Financials EvokAI Creative Labs Inc.

Equities

OKAI

CA30053J1012

Advanced Medical Equipment & Technology

Delayed Toronto S.E. 15:15:59 2024-04-30 EDT 5-day change 1st Jan Change
0.13 CAD -.--% Intraday chart for EvokAI Creative Labs Inc. -.--% +73.33%

Valuation

Fiscal Period: December 2023
Capitalization 1 4.303
Enterprise Value (EV) 2 4.315
P/E ratio -0.22 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
EV / FCF 2,260,966 x
FCF Yield 0%
Price to Book -15.1 x
Nbr of stocks (in thousands) 76,055
Reference price 3 0.0566
Announcement Date 24-04-29
1USD in Million2CAD in Million3USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales - - -
EBITDA - - -
EBIT 1 -0.0717 -0.4351 -2.257
Operating Margin - - -
Earnings before Tax (EBT) 1 -0.0861 -0.4718 -17.08
Net income 1 -0.0861 -0.4718 -17.08
Net margin - - -
EPS 2 -0.0120 -0.0597 -0.2525
Free Cash Flow - -0.1287 1.909
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 23-04-27 23-04-27 24-04-29
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 - 0.04 0.01
Net Cash position 1 0.04 - -
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -0.13 1.91
ROE (net income / shareholders' equity) - 543% 3,617%
ROA (Net income/ Total Assets) - -914% -321%
Assets 1 - 0.0516 5.316
Book Value Per Share 2 0 -0 -0
Cash Flow per Share 2 0.0100 0 0.0100
Capex - - -
Capex / Sales - - -
Announcement Date 23-04-27 23-04-27 24-04-29
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. OKAI Stock
  4. Financials EvokAI Creative Labs Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW